Life Sciences Archive » January, 2007

Life Sciences - January, 2007

136 articles

• Dr. Shielded From Wyeth's Bid To Compel Info
• Senate Bill Would Ban Authorized Generics
• Express Scripts To Resubmit Antitrust Filing
• Court Rules In Pfizer's Favor In Norvasc Patent Case
• FDA Reveals Big Changes In Tracking Drug Safety
• Punitive Damages To Proceed In Prempro Trial
• Backdating Charges Surface In Caremark Row
• Pfizer's Painkiller Class Action Grows
• Group Opposes Caremark, Express Scripts Union
• Firm Names First African-American Dept. Head
• Court Blocks Israeli Co. From Suing Amgen
• Judge Refuses To Toss Aredia Plaintiffs
• DOJ: Roxane Bilked Medicare, Medicaid
• Wyeth Denied Summary Judgment
• Amid Uproar, Novartis Files Gleevec Appeal
• FTC Takes Deeper Look At $919M Biotech Merger
• Skadden Lures Cadwalader Antitrust Trio
• Merck Wins Stay In Colorado Vioxx Case
• Wyeth Suffers Setback In Prempro Trial
• Glaxo Refutes Claims It Hid Teen Suicide Link
• Health Data Collectors Attack Prescription Law
• Thailand Breaks Patents For Plavix, HIV/AIDS Drug
• Class Denied In Paxil Case
• Pfizer's Canadian Lipitor Patent Declared Invalid
• Bayer's Trasylol Woes Trigger First Liability Suit
• Merck Accused Of Denying Overtime
• Lawmakers Scrutinize Express Scripts Bid
• Appeals Court Affirms Antitrust Dialysis Decision
• Apotex Seeks Approval For Generic Ulcer Medication
• Thailand Mulls Breaking Patents On Two Drugs
• Appeals Court Remands Syringe Patent Case
• Class Certifications Faced Challenges In 2006
• SEC Warns Cardinal Health Executive
• Teva Launches 18 Patent Suits
• Express Scripts Can Keep Lawyers, Says Judge
• Court Shakes Head At Medtronic Whistleblower
• FTC's Antitrust Case Over Birth Control Continues
• Remaining Claims Thrown Out in Alaris, ICU Case
• Lenders Object To Nellson's Extension Bid
• Judge To Consider Class In Pfizer's Neurontin Cases
• E.U. Court Advisor Rejects Bid To Close Drug Loophole
• AAI Appoints First Director Of Legal Advocacy
• Canadian Court Gives Nod To Prepulsid Class Action
• Bayer Shells Out More Over Baycol
• Cell Therapeutics To Settle For $10.5M
• Barr Sued By Celgene Over Generic Thalomid
• Attorney Destroyed Evidence In Fen-Phen Case
• Eli Lilly In Hot Seat Again Over Zyprexa
• Amgen Should Win Patent Suit, Analyst Says
• Third Prempro Trial To Begin In Arkansas
• Plavix Makers Fight For Exclusivity
• Woman Drops Vioxx Suit
• AIDS Group Sues Pfizer Over Viagra Ads
• India's Patent Laws Fall Short, Report Claims
• On Eve Of Plavix Trial, Apotex Suffers Another Blow
• Decision Showcases Debate Within Federal Circuit
• Jury Deadlocks In Two California Vioxx Cases
• Judge Values Nellson Nutraceutical At $320M
• Federal Circuit Affirms Ultracet Decision
• Antitrust Watchdog Forces Drug Divestitures
• Novogen Settles Menopause Supplement Suit
• Teva Sues Generic Zoloft Rivals
• Ex-Milberg Weiss Antitrust Partners Join Pomerantz
• CEO On Trial In Biggest South Carolina Fraud Case
• Pfizer Sues IVAX To Protect Market For Detrol
• Looking East, U.S. Law Firms Boost India Practices
• Schering-Plough Sentenced In Medicaid Fraud Case
• Merck Case Threatens Patent Term Extensions
• Lawsuits Pile Up For Antipsychotic Drug
• Stryker Faces Class Action Over Pain-Relief Device
• Senate Bill Targets Reverse Payments
• Angiotech, Boston Scientific Win Dutch Patent Case
• U.S. Competition Watchdog Decries Drug Deals
• Former Head of U.N. Oil-For-Food Program Indicted
• Massive Medicaid Case To Stay In State Court
• For IPR In India, A Time Of Sea Change
• University Says Inventor Was Left Off Hepatitis Patent
• Foley & Lardner Filed Patent Application Late: Suit
• Appeals Court Reawakens Vioxx Testing Campaign
• Italian Company Wins Patent Decision Against Purdue
• U.K. Court Affirms Ruling Revoking Stent Patent
• Canadian Pharmacists Protest U.S. Drug Exports
• Plaintiff Dismisses Chinese Vitamin C Antitrust Case
• Appeals Court Upholds $41M Ruling Against Mary Kay
• Medicare Reform Faces Challenges, Rival Proposals
• Debate On Proposed Medicare Changes Heats Up
• Bayer, Novartis Near Settlement Over MS Drug
• Digene Files Patent Suit Against Third Wave
• "MedImmune" Ushers In New Era Of Patent Litigation
• Indian Generics Companies Change Course
• Lilly To Take $495M Charge To Settle Zyprexa Suits
• FDA Seeks $87.4M Hike In Prescription Drug User Fees
• DNA Patent Suit Settled For $3.35M
• Small Drug Sellers Seek Marketing Law Change
• Abbott Hit With Permanent Injunction
• Effects Of Proposed Medicare Changes Disputed
• Ranbaxy Eyes Merck's Generics Unit
• Drug Maker Drops Patent Appeal
• Novartis Case Tests India's IP Climate
• Medtronic Faces More Suits Over Pacemaker Recall
• Congress Tackles Medicare Drug Plan
• Doctor Withdraws Patent Suit For Pain Invention
• Supreme Court Backhands Key Federal Circuit Test
• Impax Laboratories Reacts To SEC Suspension
• High Court Shakes Head At Hytrin Settlement Case
• Two Suits Attempt To Derail CVS-Caremark Merger
• ArthroCare To Settle Patent Suit For $2.75M
• India Mulls Data Protection
• Novartis Sues To Reverse USPTO Judgment
• Caremark Nixes Bid, Avoids Antitrust Scrutiny
• Supreme Court Ruling Bolsters Licensee Rights
• Judge Calls Merck Subpoena "Abusive And Arrogant"
• Caltech Launches Suit Over Microsurgical Tools
• New Bill Clears Path For $4 Generics
• Sanofi-Aventis Sued By Reps For Overtime Pay
• Assaulted Women Sue Rite Aid For Negligence
• Federal Circuit Denies Ariad's Request
• Abbott Facing Stent Injunction After French Ruling
• Appeals Court Affirms Abbott's Biaxin Injunction
• Mintz Levin Snares Health Care Partners For New York
• Novartis Hits Par With Second Lotrel Suit
• Patent Rule Changes: Preparing A Medtech Portfolio
• Law Firm Profile: Woodcock Washburn LLP
• Abbott Defeated In HCV Patent Spat
• Eli Lilly Settles Zyprexa Claims
• Drug Innovation Stalls Despite R&D Spending: Report
• Bayer, TrimSpa Settle With FTC Over Ads
• Duane Morris Wants Another Trial Against McKesson
• Synthes Sues Stryker Over Bone Plate Patent
• Fulwider Pays $8M To Settle Misconduct Claims
• Drug Makers Sued Over Cholesterol Drug
• Abbott E-Mails Could Affect Patent Evergreening Suits
• Appeals Court Nixes Savient Injunction Bid
• Eli Lilly Scores In Zyprexa Patent Feud
• Appeals Court Vacates Ventana Ruling
• DNA Sequencing Rivals Head To Court